Solid Biosciences (SLDB)
US Market

Solid Biosciences (SLDB) Stock Price & Analysis


SLDB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.40 - $14.26
Previous Close$6.14
Average Volume (3M)34.26K
Market Cap
Enterprise Value-$39.38M
Total Cash (Recent Filing)$185.51M
Total Debt (Recent Filing)$25.77M
Price to Earnings (P/E)-0.7
Aug 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.36
Shares Outstanding19,601,539
10 Day Avg. Volume11,132
30 Day Avg. Volume34,258
Standard Deviation0.31
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)232.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.89
Enterprise Value/Gross Profit-4.87
Enterprise Value/Ebitda0.36
Price Target Upside13.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Solid Biosciences’s price range in the past 12 months?
Solid Biosciences lowest stock price was $3.40 and its highest was $14.26 in the past 12 months.
    What is Solid Biosciences’s market cap?
    Currently, no data Available
    When is Solid Biosciences’s upcoming earnings report date?
    Solid Biosciences’s upcoming earnings report date is Aug 11, 2023 which is in 71 days.
      How were Solid Biosciences’s earnings last quarter?
      Solid Biosciences released its earnings results on May 11, 2023. The company reported -$1.54 earnings per share for the quarter, beating the consensus estimate of -$1.612 by $0.072.
        Is Solid Biosciences overvalued?
        According to Wall Street analysts Solid Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Solid Biosciences pay dividends?
          Solid Biosciences does not currently pay dividends.
          What is Solid Biosciences’s EPS estimate?
          Solid Biosciences’s EPS estimate is -$1.64.
            How many shares outstanding does Solid Biosciences have?
            Solid Biosciences has 19,601,540 shares outstanding.
              What happened to Solid Biosciences’s price movement after its last earnings report?
              Solid Biosciences reported an EPS of -$1.54 in its last earnings report, beating expectations of -$1.612. Following the earnings report the stock price went up 3.871%.
                Which hedge fund is a major shareholder of Solid Biosciences?
                Among the largest hedge funds holding Solid Biosciences’s share is Perceptive Advisors LLC. It holds Solid Biosciences’s shares valued at 17M.


                  Solid Biosciences Stock Smart Score

                  The Solid Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Solid Biosciences

                  Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding SLDB

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold SLDB. The ETFs are listed according to market value of SLDB within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  PTC Therapeutics
                  Ultragenyx Pharmaceutical

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis